Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye
European Journal of Clinical Microbiology & Infectious Diseases · 2024-09 · 43 (9) · 1787-1794
DOI: 10.1007/s10096-024-04896-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 12.07.2024. Verfasst von Ecem Buyukyanbolu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. nallarecem@gmail.com. Hauptthemen laut MEDLINE: Drug Combinations, Cephalosporins, Ceftazidime, Azabicyclo Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. nallarecem@gmail.com.
- Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA. nallarecem@gmail.com.
- Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
- Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA.
- Department of Medical Microbiology, Health Sciences University, Istanbul, Turkey.
- Department of Medical Microbiology, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey.
Zitieren
APA
Buyukyanbolu, E., Genc, L., Cyr, E. A., Karakus, M., Comert, F., Otlu, B., Aktas, E., & Nicolau, D. P. (2024). Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye. European Journal of Clinical Microbiology & Infectious Diseases, 43(9), 1787-1794. https://doi.org/10.1007/s10096-024-04896-7
Vancouver
Buyukyanbolu E, Genc L, Cyr EA, Karakus M, Comert F, Otlu B, et al. Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(9):1787-1794. doi:10.1007/s10096-024-04896-7
BibTeX
@article{Buyukyanbolu2024,
author = {Buyukyanbolu, Ecem and Genc, Leyla and Cyr, Elizabeth A and Karakus, Mehmet and Comert, Fusun and Otlu, Baris and Aktas, Elif and Nicolau, David P},
title = {Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
volume = {43},
number = {9},
pages = {1787--1794},
doi = {10.1007/s10096-024-04896-7}
}
EUVIMED